Merck Ventures
Finance · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18 Hakishon St, Yavne, Central District,...Phone Number
(408) 600-8138Website
www.m-ventures.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Merck Ventures
M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact the company's core business areas. From its headquarters in Amsterdam and offices in the US and Israel, M Ventures invests globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early stage investing and company creation including the creation of spin-offs to leverage the company's science and technology base.Explore more
Merck Ventures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Merck Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Merck Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Merck Ventures has recently received funding, and reach out quickly before it becomes old news!
Click to see if Merck Ventures had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Merck Ventures
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Merck Ventures has new funding data
Check out if Merck Ventures is spiking on competitors!
Product Launch: Get notified when Merck Ventures launches new products
Earning: See what the market has to say on Merck Ventures recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Merck Ventures
Find 3 more new buyers
Company Profile Activity
Activity Insights
Merck Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Merck Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Merck Ventures.
Merck Ventures Tech Stack
A closer look at the technologies used by Merck Ventures
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Merck Ventures News & Media
Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion
Paris, July 07, 2026 (GLOBE NEWSWIRE) -- Cyllene Therapeutics, formerly known as EG 427, today announced the successful closing of a €33 million Series C financing led by new investors GordonMD Global Investments® LP (“GordonMD”) and M Ventures. Existing investors including Andera Partners SAS, Bpifrance Investissement through its InnoBio 3 Fund, L.P. and Lamond Ventures LLC also participated in the round.Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital and others Led by founder and drug discovery expert Dr. Andreas Goutopoulos, Actithera's proprietary...NovoLINC Secures Investments to Assist AI Computing with Groundbreaking Thermal Interface Technology
PITTSBURGH, Jan. 21, 2025 /PRNewswire/ -- NovoLINC, a thermal technology startup spun out of Carnegie Mellon University, announced seed funding led by M Ventures, with participation from Foothill Ventures and TDK Ventures. NovoLINC's breakthrough nanocomposite thermal solutions reduce...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Merck Ventures
Sign Up For FreeTo access detailed company insights
M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact the company's core business areas. From its headquarters in Amsterdam and offices in the US and Israel, M Ventures invests globally in transformational ideas driven by great... Read More
